Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally designed for type 2 diabetes management have emerged as one of the most powerful pharmacological tools for sustainable weight reduction
News provided by Calibrate Health, Inc May 05, 2026, 11:00 ET Data supports sustained weight loss across diverse populations NEW YORK, May 5, 2026 /PRNewswire/ -- Calibrate, the first integrated clinical and coaching solution for obesity care, today released its 2026 Results Report which draws on one of the largest real-world datasets in behavior-assisted obesity management: more than 50,000 members drawn from nearly six years of clinical data
An injectable medication used to treat visceral spasms and poor blood circulation was found to contain glass particulate matter
Ianlz HS, Chowdhury MM, Motley RJ: Lupus erythematosus/lichen planus overlap syndrome with scarring alopecia
Ingredients 1 Capsule: Acetyl L-Carnitine HCI 1,000 mg